Charles Schwab Investment Management Inc Recursion Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,940,680 shares of RXRX stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,940,680

Previous 1,651,754 17.49%

Holding current value

$12 Million

Previous $12.4 Million 3.24%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.92 - $8.6 $1.71 Million - $2.48 Million	288,926 Added 17.49%	1,940,680 $12.8 Million
Q2 2024 Aug 12, 2024	BUY	$7.35 - $10.05 $3.22 Million - $4.41 Million	438,742 Added 36.17%	1,651,754 $12.4 Million
Q1 2024 May 08, 2024	BUY	$9.13 - $15.52 $202,046 - $343,457	22,130 Added 1.86%	1,213,012 $12.1 Million
Q4 2023 Feb 06, 2024	BUY	$5.09 - $10.79 $167,542 - $355,163	32,916 Added 2.84%	1,190,882 $11.7 Million
Q3 2023 Nov 08, 2023	BUY	$6.59 - $15.86 $1.04 Million - $2.49 Million	157,189 Added 15.71%	1,157,966 $8.86 Million
Q2 2023 Aug 09, 2023	BUY	$4.56 - $9.94 $76,781 - $167,369	16,838 Added 1.71%	1,000,777 $7.48 Million
Q1 2023 May 11, 2023	SELL	$6.42 - $9.64 $4,763 - $7,152	-742 Reduced 0.08%	983,939 $6.56 Million
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $574,067 - $1.02 Million	80,177 Added 8.86%	984,681 $7.59 Million
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $3.73 Million - $6.48 Million	476,162 Added 111.16%	904,504 $9.62 Million
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.26 $278,097 - $510,948	55,178 Added 14.79%	428,342 $3.49 Million
Q1 2022 May 13, 2022	SELL	$6.16 - $18.03 $25,102 - $73,472	-4,075 Reduced 1.08%	373,164 $2.67 Million
Q4 2021 Feb 11, 2022	BUY	$16.14 - $21.86 $3.14 Million - $4.25 Million	194,467 Added 106.4%	377,239 $6.46 Million
Q3 2021 Nov 16, 2021	BUY	$19.03 - $41.33 $340,465 - $739,435	17,891 Added 10.85%	182,772 $4.21 Million
Q2 2021 Aug 16, 2021	BUY	$18.0 - $37.42 $2.97 Million - $6.17 Million	164,881 New	164,881 $6.02 Million

Others Institutions Holding RXRX

# of Institutions

286

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.12B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Recursion Pharmaceuticals, Inc. Transaction History